Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner

Journal of Bone and Mineral Research

Volumn 23, Issue 3, 2008, Pages 361-372

  Jensen, Eric D ^a   Schroeder, Tania M ^b   Bailey, Jaclyn ^c   Gopalakrishnan, Rajaram ^d   Westendorf, Jennifer J ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e MAYO CLINIC   (United States)

Author keywords

BMP2; Cbfa1; Co repressor; HDAC7; Osteoblast; Runx2

Indexed keywords

CELL MARKER; HISTONE DEACETYLASE; HISTONE DEACETYLASE 10; HISTONE DEACETYLASE 11; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE INHIBITOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; OSTEOBLAST; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

EID: 39749130325     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.071104     Document Type: Article

References (62)

1. 1 Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR 1997 Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773–779.
2. 2 Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755–764.
3. 3 Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765–771.
4. 4 Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, Van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M 2003 Regulation of the bone‐specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 23: 3339–3351.
5. 5 Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW 2000 A mechanism of repression by acute myeloid leukemia‐1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem 275: 651–656.
6. 6 Aronson BD, Fisher AL, Blechman K, Caudy M, Gergen JP 1997 Groucho‐dependent and ‐independent repression activities of Runt domain proteins. Mol Cell Biol 17: 5581–5587.
7. 7 Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y 1999 A WW domain‐containing yes‐associated protein (YAP) is a novel transcriptional co‐activator. EMBO J 18: 2551–2562.
8. 8 Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS 2004 Tyrosine phosphorylation controls Runx2‐mediated subnuclear targeting of YAP to repress transcription. EMBO J 23: 790–799.
9. 9 Schroeder TM, Kahler RA, Li X, Westendorf JJ 2004 Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem 279: 41998–42007.
10. 10 Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN 2004 Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119: 555–566.
11. 11 Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, Yoshida M, Stein GS, Li X 2002 Runx2 (Cbfa1, AML‐3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol 22: 7982–7992.
12. 12 Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, Oh BC, Lee KS, Lee YH, Bae SC 2006 Bone morphogenetic protein‐2 stimulates Runx2 acetylation. J Biol Chem 281: 16502–16511.
13. 13 Verdin E, Dequiedt F, Kasler HG 2003 Class II histone deacetylases: Versatile regulators. Trends Genet 19: 286–293.
14. 14 Yang XJ, Gregoire S 2005 Class II histone deacetylases: From sequence to function, regulation, and clinical implication. Mol Cell Biol 25: 2873–2884.
15. 15 Dequiedt F, Kasler H, Fischle W, Kiermer V, Weinstein M, Herndier BG, Verdin E 2003 HDAC7, a thymus‐specific class II histone deacetylase, regulates Nur77 transcription and TCR‐mediated apoptosis. Immunity 18: 687–698.
16. 16 Fischle W, Emiliani S, Hendzel MJ, Nagase T, Nomura N, Voelter W, Verdin E 1999 A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J Biol Chem 274: 11713–11720.
17. 17 Grozinger CM, Hassig CA, Schreiber SL 1999 Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96: 4868–4873.
18. 18 Kao HY, Downes M, Ordentlich P, Evans RM 2000 Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT‐mediated repression. Genes Dev 14: 55–66.
19. 19 Fischle W, Dequiedt F, Fillion M, Hendzel MJ, Voelter W, Verdin E 2001 Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J Biol Chem 276: 35826–35835.
20. 20 Petrie K, Guidez F, Howell L, Healy L, Waxman S, Greaves M, Zelent A 2003 The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 278: 16059–16072.
21. 21 Verdel A, Khochbin S 1999 Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation‐dependent chromatin modifiers. J Biol Chem 274: 2440–2445.
22. 22 Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th'ng J, Han J, Yang XJ 1999 HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19: 7816–7827.
23. 23 Zhou X, Marks PA, Rifkind RA, Richon VM 2001 Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci USA 98: 10572–10577.
24. 24 Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, Muscat GE 2001 A dynamic role for HDAC7 in MEF2‐mediated muscle differentiation. J Biol Chem 276: 17007–17013.
25. 25 Grozinger CM, Schreiber SL 2000 Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14‐3‐3‐dependent cellular localization. Proc Natl Acad Sci USA 97: 7835–7840.
26. 26 McKinsey TA, Zhang CL, Lu J, Olson EN 2000 Signal‐dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408: 106–111.
27. 27 McKinsey TA, Zhang CL, Olson EN 2000 Activation of the myocyte enhancer factor‐2 transcription factor by calcium/calmodulin‐dependent protein kinase‐stimulated binding of 14‐3‐3 to histone deacetylase 5. Proc Natl Acad Sci USA 97: 14400–14405.
28. 28 Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T 1999 HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18: 5099–5107.
29. 29 Wang AH, Kruhlak MJ, Wu J, Bertos NR, Vezmar M, Posner BI, Bazett‐Jones DP, Yang XJ 2000 Regulation of histone deacetylase 4 by binding of 14‐3‐3 proteins. Mol Cell Biol 20: 6904–6912.
30. 30 Kao HY, Verdel A, Tsai CC, Simon C, Juguilon H, Khochbin S 2001 Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem 276: 47496–47507.
31. 31 Downes M, Ordentlich P, Kao HY, Alvarez JG, Evans RM 2000 Identification of a nuclear domain with deacetylase activity. Proc Natl Acad Sci USA 97: 10330–10335.
32. 32 Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, Verdin E 2002 Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N‐CoR. Mol Cell 9: 45–57.
33. 33 Huang EY, Zhang J, Miska EA, Guenther MG, Kouzarides T, Lazar MA 2000 Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3‐independent repression pathway. Genes Dev 14: 45–54.
34. 34 Zhang CL, McKinsey TA, Lu JR, Olson EN 2001 Association of COOH‐terminal‐binding protein (CtBP) and MEF2‐interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem 276: 35–39.
35. 35 Zhang CL, McKinsey TA, Olson EN 2002 Association of class II histone deacetylases with heterochromatin protein 1: Potential role for histone methylation in control of muscle differentiation. Mol Cell Biol 22: 7302–7312.
36. 36 Chan JK, Sun L, Yang XJ, Zhu G, Wu Z 2003 Functional characterization of an amino‐terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. J Biol Chem 278: 23515–23521.
37. 37 Lee HW, Suh JH, Kim AY, Lee YS, Park SY, Kim JB 2006 Histone deacetylase‐mediated histone modification regulates osteoblast differentiation. Mol Endocrinol 20: 2432–2443.
38. 38 de Boer J, Licht R, Bongers M, Klundert TV, Arends R, Blitterswijk CV 2006 Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng 12: 2927–2937.
39. 39 Cho HH, Park HT, Kim YJ, Bae YC, Suh KT, Jung JS 2005 Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem 96: 533–542.
40. 40 Schroeder TM, Westendorf JJ 2005 Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 20: 2254–2263.
41. 41 Zaidi SK, Javed A, Choi JY, van Wijnen AJ, Stein JL, Lian JB, Stein GS 2001 A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci 114: 3093–3102.
42. 42 Javed A, Gutierrez S, Montecino M, van Wijnen AJ, Stein JL, Stein GS, Lian JB 1999 Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D‐responsive transcription and contribute to chromatin organization. Mol Cell Biol 19: 7491–7500.
43. 43 Zhang C, Basta T, Jensen ED, Klymkowsky MW 2003 The beta‐catenin/VegT‐regulated early zygotic gene Xnr5 is a direct target of SOX3 regulation. Development 130: 5609–5624.
44. 44 Lindenmuth DM, van Wijnen AJ, Hiebert S, Stein JL, Lian JB, Stein GS 1997 Subcellular partitioning of transcription factors during osteoblast differentiation: Developmental association of the AML/CBF alpha/PEBP2 alpha‐related transcription factor‐NMP‐2 with the nuclear matrix. J Cell Biochem 66: 123–132.
45. 45 Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW 1997 Identification of a nuclear matrix targeting signal in the leukemia and bone‐related AML/CBF‐alpha transcription factors. Proc Natl Acad Sci USA 94: 6746–6751.
46. 46 Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa‐Sehara A, Suda T 1994 Bone morphogenetic protein‐2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755–1766.
47. 47 Lu J, McKinsey TA, Zhang CL, Olson EN 2000 Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6: 233–244.
48. 48 Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN 2006 Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126: 321–334.
49. 49 Franceschi RT, Xiao G 2003 Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88: 446–454.
50. 50 Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javed A, Zaidi SK, Young DW, Choi JY, Pockwinse SM 2004 Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23: 4315–4329.
51. 51 McKinsey TA, Zhang CL, Olson EN 2001 Identification of a signal‐responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol 21: 6312–6321.
52. 52 Zhang CL, McKinsey TA, Olson EN 2001 The transcriptional corepressor MITR is a signal‐responsive inhibitor of myogenesis. Proc Natl Acad Sci USA 98: 7354–7359.
53. 53 Dequiedt F, Van Lint J, Lecomte E, Van Duppen V, Seufferlein T, Vandenheede JR, Wattiez R, Kettmann R 2005 Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor‐induced Nur77 expression and apoptosis. J Exp Med 201: 793–804.
54. 54 Matthews SA, Liu P, Spitaler M, Olson EN, McKinsey TA, Cantrell DA, Scharenberg AM 2006 Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol 26: 1569–1577.
55. 55 Parra M, Kasler H, McKinsey TA, Olson EN, Verdin E 2005 Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T‐cell receptor activation. J Biol Chem 280: 13762–13770.
56. 56 Sparrow DB, Miska EA, Langley E, Reynaud‐Deonauth S, Kotecha S, Towers N, Spohr G, Kouzarides T, Mohun TJ 1999 MEF‐2 function is modified by a novel co‐repressor, MITR. EMBO J 18: 5085–5098.
57. 57 Zhou X, Richon VM, Rifkind RA, Marks PA 2000 Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. Proc Natl Acad Sci USA 97: 1056–1061.
58. 58 Liu F, Dowling M, Yang XJ, Kao GD 2004 Caspase‐mediated specific cleavage of human histone deacetylase 4. J Biol Chem 279: 34537–34546.
59. 59 Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C 2004 Caspase‐dependent regulation of histone deacetylase 4 nuclear‐cytoplasmic shuttling promotes apoptosis. Mol Biol Cell 15: 2804–2818.
60. 60 Zeng C, McNeil S, Pockwinse S, Nickerson J, Shopland L, Lawrence JB, Penman S, Hiebert S, Lian JB, van Wijnen AJ, Stein JL, Stein GS 1998 Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix‐associated transcriptional domains. Proc Natl Acad Sci USA 95: 1585–1589.
61. 61 Choi JY, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS 2001 Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue‐specific differentiation during embryonic development. Proc Natl Acad Sci USA 98: 8650–8655.
62. 62 Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS 2005 Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci USA 102: 1454–1459.